| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/16/2023 | 63.11% | RBC Capital | → $13 | Initiates Coverage On | → Outperform |
| 04/28/2023 | 150.94% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
| 04/12/2023 | 150.94% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
| 03/28/2023 | 251.32% | Ladenburg Thalmann | $27 → $28 | Maintains | Buy |
| 03/14/2023 | 150.94% | HC Wainwright & Co. | $21 → $20 | Reiterates | → Buy |
| 01/06/2023 | 125.85% | Piper Sandler | $10 → $18 | Upgrades | Neutral → Overweight |
| 10/28/2022 | 25.47% | Piper Sandler | $7 → $10 | Maintains | Neutral |
| 10/28/2022 | 163.49% | HC Wainwright & Co. | $20 → $21 | Maintains | Buy |
| 02/25/2022 | 150.94% | HC Wainwright & Co. | $22 → $20 | Maintains | Buy |
| 07/30/2021 | 176.04% | HC Wainwright & Co. | $25 → $22 | Maintains | Buy |
| 07/16/2021 | 144.67% | B. Riley Securities | → $19.5 | Upgrades | Neutral → Buy |
| 03/09/2021 | — | Northland Capital Markets | Upgrades | Market Perform → Outperform | |
| 01/29/2021 | 150.94% | Piper Sandler | $28 → $20 | Downgrades | Overweight → Neutral |
| 01/28/2021 | — | Northland Capital Markets | Downgrades | Outperform → Market Perform | |
| 09/14/2020 | 213.68% | HC Wainwright & Co. | → $25 | Upgrades | Neutral → Buy |
| 09/09/2020 | 182.31% | Northland Capital Markets | → $22.5 | Upgrades | Market Perform → Outperform |
| 07/29/2020 | 251.32% | B. Riley Securities | → $28 | Upgrades | Neutral → Buy |
| 07/29/2020 | 213.68% | HC Wainwright & Co. | $30 → $25 | Maintains | Neutral |
| 07/20/2020 | 276.41% | Piper Sandler | → $30 | Initiates Coverage On | → Overweight |
| 07/13/2020 | — | B. Riley Securities | Downgrades | Buy → Neutral | |
| 07/10/2020 | 276.41% | HC Wainwright & Co. | $20 → $30 | Reiterates | → Neutral |
| 06/16/2020 | 163.49% | Northland Capital Markets | → $21 | Downgrades | Outperform → Market Perform |
| 05/29/2020 | 219.95% | B. Riley Securities | $18.5 → $25.5 | Maintains | Buy |
| 05/19/2020 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 04/29/2020 | 150.94% | HC Wainwright & Co. | $15 → $20 | Reiterates | → Buy |
| 03/30/2020 | 132.12% | B. Riley Securities | $20.5 → $18.5 | Maintains | Buy |
| 02/28/2020 | 88.21% | HC Wainwright & Co. | $13 → $15 | Reiterates | → Buy |
| 02/26/2020 | 63.11% | HC Wainwright & Co. | $12 → $13 | Reiterates | → Buy |
| 02/21/2020 | 147.8% | B. Riley Securities | $12 → $19.75 | Maintains | Buy |
| 10/22/2019 | 50.56% | B. Riley Securities | $10.75 → $12 | Maintains | Buy |
| 09/23/2019 | 50.56% | HC Wainwright & Co. | → $12 | Initiates Coverage On | → Buy |
| 08/02/2019 | 34.88% | B. Riley Securities | $9 → $10.75 | Maintains | Buy |
What is the target price for Zynex (ZYXI)?
The latest price target for Zynex (NASDAQ: ZYXI) was reported by RBC Capital on October 16, 2023. The analyst firm set a price target for $13.00 expecting ZYXI to rise to within 12 months (a possible 63.11% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zynex (ZYXI)?
The latest analyst rating for Zynex (NASDAQ: ZYXI) was provided by RBC Capital, and Zynex initiated their outperform rating.
When is the next analyst rating going to be posted or updated for Zynex (ZYXI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zynex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zynex was filed on October 16, 2023 so you should expect the next rating to be made available sometime around October 16, 2024.
Is the Analyst Rating Zynex (ZYXI) correct?
While ratings are subjective and will change, the latest Zynex (ZYXI) rating was a initiated with a price target of $0.00 to $13.00. The current price Zynex (ZYXI) is trading at is $7.97, which is within the analyst's predicted range.